Category: 3. Business

  • European Growth Companies With High Insider Ownership And Up To 113% Earnings Growth

    European Growth Companies With High Insider Ownership And Up To 113% Earnings Growth

    As the pan-European STOXX Europe 600 Index remains relatively stable amid mixed returns in major stock indexes, investors are closely monitoring economic indicators such as eurozone inflation and labor market trends. In this environment, growth companies with high insider ownership can be particularly appealing, as they often demonstrate strong alignment between management and shareholder interests, potentially leading to robust earnings growth.

    Name

    Insider Ownership

    Earnings Growth

    Xbrane Biopharma (OM:XBRANE)

    21.8%

    56.8%

    Pharma Mar (BME:PHM)

    11.8%

    44.9%

    MedinCell (ENXTPA:MEDCL)

    13.9%

    130.8%

    Marinomed Biotech (WBAG:MARI)

    29.7%

    20.2%

    KebNi (OM:KEBNI B)

    38.3%

    94.5%

    Elliptic Laboratories (OB:ELABS)

    24.4%

    79%

    CTT Systems (OM:CTT)

    17.5%

    34.2%

    Circus (XTRA:CA1)

    24.7%

    94.8%

    Bonesupport Holding (OM:BONEX)

    10.4%

    57.5%

    Bergen Carbon Solutions (OB:BCS)

    12%

    63.2%

    Click here to see the full list of 218 stocks from our Fast Growing European Companies With High Insider Ownership screener.

    Here we highlight a subset of our preferred stocks from the screener.

    Simply Wall St Growth Rating: ★★★★☆☆

    Overview: Sectra AB (publ) operates in the medical IT and cybersecurity sectors across Sweden, the United Kingdom, the Netherlands, and other parts of Europe, with a market capitalization of approximately SEK68.52 billion.

    Operations: The company’s revenue is primarily derived from Imaging IT Solutions at SEK2.80 billion and Secure Communications at SEK406.96 million, with additional contributions from Business Innovation amounting to SEK90.76 million.

    Insider Ownership: 16.3%

    Earnings Growth Forecast: 18.2% p.a.

    Sectra’s growth trajectory is supported by robust insider ownership and strategic expansion in digital pathology and AI-enhanced imaging solutions. Recent contracts with healthcare systems in the US, Canada, and Australia highlight its focus on integrated diagnostics and cloud services, enhancing operational efficiency. Despite moderate insider trading activity recently, Sectra’s revenue growth outpaces the Swedish market at 15.3% annually. Earnings are projected to grow faster than the market average at 18.2% per year.

    OM:SECT B Earnings and Revenue Growth as at Jul 2025

    Simply Wall St Growth Rating: ★★★★☆☆

    Overview: Landis+Gyr Group AG, along with its subsidiaries, offers integrated energy management solutions to the utility sector across the Americas, Europe, the Middle East, Africa, and the Asia Pacific with a market cap of CHF1.70 billion.

    Continue Reading

  • Hitachi develops “Metaverse Platform for Nuclear Power Plants” to enhance efficiency in construction and maintenance operations : July 9, 2025

    Hitachi develops “Metaverse Platform for Nuclear Power Plants” to enhance efficiency in construction and maintenance operations : July 9, 2025

    • Combined Hitachi Group’s expertise in the nuclear energy business with its digital technologies to develop a platform utilizing a metaverse and AI solution.

    • Streamlines operations from design, on-site construction and maintenance to asset management by enabling the sharing of site conditions with electric utilities and partners such as constructors through a high-precision digital twin of nuclear facilities in a metaverse.



    Image of virtual spaces recreated on-site and related functions in the Metaverse Platform for Nuclear Power Plants

    Tokyo, July 9, 2025 Hitachi, Ltd. (TSE:6501, “Hitachi”), announced today the development of a new “Metaverse Platform for Nuclear Power Plants” that leverages a metaverse and AI technology to streamline operations, including nuclear power plants’ safety enhancement, new plant construction, maintenance, and decommissioning. The platform recreates nuclear power plants in a metaverse using high-precision point cloud data and 3D CAD data, and aims to enhance productivity in information sharing, schedule coordination, and asset management among stakeholders by utilizing it with partners such as electric utilities and contractors.

    It is also designed to serve as the foundation of a “Data-Driven Power Plant,” which we aim to establish to address the diverse needs and challenges faced by electric utilities–such as improving equipment reliability, enhancing work management, and increasing operational efficiency–through data-driven value creation and problem-solving. This new platform embodies Lumada 3.0, which uses Hitachi’s domain knowledge and AI to convert data into value to solve challenges faced by customers and society, and was developed together with GlobalLogic as One Hitachi, integrating Hitachi’s decades-long expertise in the nuclear energy business with its Group-wide advanced digital technologies. The platform facilitates the collection, aggregation, and analysis of on-site data, thereby supporting optimal investment planning and plant maintenance through data-driven insights.

    Background

    In the installation of new equipment or modification in nuclear power plants, precise planning and reliable execution are essential to complete on-site work within the shortest possible timeframe. However, access to nuclear power plants is often restricted by regulations, limiting the frequency and duration of site surveys. In some cases, controlled zones are not accessible during operation, restricting on-site surveys. These constraints require extensive coordination among stakeholders, with electric utilities playing a central role in sharing information and revising work plans.

    Moreover, following the Great East Japan Earthquake, all domestic nuclear power plants were shut down for extended periods. During this time, the industry experienced a wave of retirements among highly skilled and knowledgeable personnel, a decline in on-site training opportunities for new plant construction, and a shrinking labor force due to demographic changes such as an aging population and declining birthrate. These factors have made knowledge transfer and productivity enhancement pressing challenges across the nuclear sector.

    In response, Hitachi has developed the Metaverse Platform for Nuclear Power Plants to further enhance productivity by enabling accurate understanding and seamless sharing of site conditions among stakeholders, real-time schedule coordination, and reduction of rework.

    Key Features of the Metaverse Platform of Nuclear Power Plants

    1. Point Cloud Data & CAD alignment

      Overlays high-precision, high-density point cloud data*1 and 3D CAD*2 models to recreate nuclear power plants in a metaverse. This enables precise verification of site conditions and identification of discrepancies between drawings and actual structures.

    2. AI Search

      Incorporates natural language processing to allow full-text and synonym-based searches of design documentation. Location and equipment-specific data in the metaverse enhances search accuracy.

    3. Multi-User Collaboration

      Supports simultaneous access to the metaverse by multiple users, facilitating real-time communication and decision-making across geographically dispersed stakeholders.

    4. Engineering Support Tools

      Offers centimeter-level measurement capabilities, virtual meetings, annotation, file attachment to specific equipment or areas, equipment layout search, and asset information linking functions to assist engineering operations.

    5. Security

      Ensures secure communication through encrypted interactions in the metaverse and access control limited to authorized users.

    *1

    A dense collection of spatial points captured by 3D scanners or cameras, used to represent the shape of objects or environments in three dimensions.


    *2

    Computer Aided Design software used for creating and editing engineering drawings and models digitally.


    Future Applications and Vision

    The Metaverse Platform for Nuclear Power Plants is designed to serve as the foundation for a “Data-Driven Power Plant”, enabling the collection, aggregation, and analysis of on-site data such as equipment conditions. This will facilitate optimal investment and maintenance planning by detecting failures in advance and predicting future equipment conditions, thereby realizing data-driven decision-making. This enables Hitachi to address the diverse needs and challenges faced by electric utilities–such as improving equipment reliability, enhancing work management, and increasing operational efficiency–through data-driven value creation and problem-solving.


    [image]Conceptual image of a data-driven power plant
    Conceptual image of a data-driven power plant

    Website of the Metaverse Platform for Nuclear Power Plants

    Introduction at Hitachi Social Innovation Forum 2025 JAPAN, OSAKA

    The Metaverse Platform of Nuclear Power Plants will be showcased at “Hitachi Social Innovation Forum 2025 JAPAN, OSAKA” held on July 17th (Thu).

    Learn more about the service at ” BS01-03: Integrating Energy and Digital Technology for a Sustainable Future” (July 17th 11:50~12:40) and the exhibition “EX01-04: Next-Generation Workstyles in the Nuclear Industry Using Hitachi’s Metaverse.”

    For more information on “Hitachi Social Innovation Forum 2025 JAPAN, OSAKA”, please visit the official website at: https://www.service.event.hitachi/en/regist/

    About Hitachi, Ltd.

    Through its Social Innovation Business (SIB) that brings together IT, OT(Operational Technology) and products, Hitachi contributes to a harmonized society where the environment, wellbeing, and economic growth are in balance. Hitachi operates globally in four sectors – Digital Systems & Services, Energy, Mobility, and Connective Industries – and the Strategic SIB Business Unit for new growth businesses. With Lumada at its core, Hitachi generates value from integrating data, technology and domain knowledge to solve customer and social challenges. Revenues for FY2024 (ended March 31, 2025) totaled 9,783.3 billion yen, with 618 consolidated subsidiaries and approximately 280,000 employees worldwide. Visit us at www.hitachi.com.

    Information contained in this news release is current as of the date of the press announcement, but may be subject to change without prior notice.

    Continue Reading

  • Financing real economy transitions in emerging markets: Learnings from global experiences

    Financing real economy transitions in emerging markets: Learnings from global experiences

    Corporate climate transition plans, once seen as internal strategy documents, are now emerging as critical tools to unlock sustainable finance and guide real economy decarbonisation. The virtual dialogue brought together Indian and emerging market voices to examine how credible transition planning can serve as a linchpin for capital mobilisation, regulatory alignment, and long-term resilience. The webinar was divided into two sessions- The first panel discussion focused on corporate transition plans and system-level enablers while the second panel reflected on the role of regulators in strengthening transition plan disclosures.

    Greening the real economy in emerging markets like India presents a dual challenge: the need to decarbonise while meeting developmental priorities. At the same time, it offers a historic opportunity to recalibrate capital flows. India’s climate goals demand an estimated $10 trillion over the coming decades, an investment that must be front-loaded to avoid a disorderly, and more expensive, transition. This makes access to global capital essential. Yet, financing will only follow credible pathways. The first panel delved into what makes a transition plan not only ambitious but effective.

    The message was clear: corporate decarbonization strategies must be rooted in local context and supported by enabling ecosystems. In India, a handful of major corporates have declared net-zero ambitions, but comprehensive, forward-looking transition plans remain rare. With coal still dominant and transitional technologies underdeveloped, Piyush Jha from Tata Steel emphasized that India must carve its own path, one that is pragmatic, yet forward-looking. As greenwashing concerns grow, particularly in hard-to-abate sectors like steel and cement, the need for robust, transparent, and context-sensitive planning has become more urgent. Investors, as Ivy Lau, Mizuho Bank noted, are moving beyond climate pledges to assess tangible progress: Are companies running pilots? Shifting fuels? Making measurable investments? Without demonstrable movement, access to transition finance, whether through bonds, loans, or blended capital, will remain limited.

    India’s unique context further reinforces the need for customised strategies. Gireesh Shrimali, Oxford Sustainable Finance Group, highlighted that credible national transition plans must be backed by concrete policies and actions, as national ambition is ultimately the sum of all corporate ambitions. Without alignment and credibility at both levels, national targets risk remaining unachieved.

    Speakers also highlighted the enabling role of ecosystem levers, from defining credible transition assets and decarbonisation roadmaps to building assurance capacity and sectoral guidance. With too many tools and benchmarks in play, companies need clarity and convergence to plan effectively and signal progress to stakeholders. Ultimately, transition plans should be seen as tools to inform finance, policy, and technology ecosystems, and in turn be shaped by them.

    The second session turned the spotlight on regulatory frameworks and the evolving role of supervisors. Dien Sukmarini, OJK, emphasized that regulatory guidelines should be created through regular engagement with industry players to understand their challenges and expectations. Disclosure, when mandated, must be matched by supervisory review, board-level capacity-building, and forward-looking metrics. Only then can transition plans shift from paper to practice. Ramnath N. Iyer, IEEFA, emphasised the importance of robust taxonomies that define what constitutes “transition”, particularly for hard-to-abate sectors navigating complex shifts.

    The discussion reaffirmed that transition is not a cost, it is a strategic lever for resilience and growth. As Ira from CETEx noted, transition planning not only mitigates climate risk but improves business resilience, reducing exposure to energy volatility and physical climate risks. While transparency is essential, transition planning frameworks must also account for external dependencies and the unpredictable nature of policy, technology, and physical climate risks.

    As Neha Kumar, Climate Bonds Initiative, summarized, ambition is a two-way street, both corporates and policymakers need to raise the bar. Transition plans should be treated as growth strategies, not just environmental blueprints. With sectoral roadmaps, robust taxonomies, investor alignment, and regulatory clarity, India can move from commitments to scalable, ecosystem-wise implementation.

    Transition planning, when done right, becomes more than a corporate tool, it becomes a platform for coordination across markets and policy. The path to net-zero will be paved by those who plan ambitiously, act decisively, and collaborate widely.

    About the India initiative on Climate Risk and Sustainable Finance

    “India Initiative on Climate Risks and Sustainable Finance (IICRSF)” led by the Climate Bonds Initiative with its partners ODI Global and auctusESG is a collaborative endeavor with the overarching purpose of supporting the efforts of financial regulators and policy makers at navigating the imminent transition, and simultaneously preparing and engaging with banks, DFIs, businesses on disclosures, transition plans and finance, building the required narrative and consensus, and supporting with the tools needed to augment financial flows from domestic and international https://www.climatebonds.net/regions/south-asia

    Webinar event with IEEFA, Climate Bonds, ODI Global and auctusESG

    Article also published on Climate Bonds

    Continue Reading

  • Merck nears $10bn deal for respiratory drugmaker Verona

    Merck nears $10bn deal for respiratory drugmaker Verona

    Unlock the Editor’s Digest for free

    Merck is nearing a roughly $10bn deal to buy lung disease-focused biotech Verona Pharma, the US drugmaker’s biggest acquisition in two years as it expands in respiratory medicine.

    The acquisition of Verona would enhance the New Jersey-based pharmaceutical company’s pipeline with the addition of Ohtuvayre, a medicine approved in the US to treat chronic obstructive pulmonary disease (COPD), which analysts predict could generate peak annual sales of nearly $4bn by the mid-2030s. The drug is also in trials as a potential treatment for other lung conditions.  

    The acquisition, which would be Merck’s largest since its $10.8bn takeover of Prometheus Biosciences in 2023, is the latest example of a pharmaceutical group targeting a biotech with an approved product already generating revenue to fill the gap left by blockbuster drugs coming off patent.

    Merck’s cancer treatment Keytruda, the world’s top-selling drug with nearly $30bn a year in revenue, is coming off patent and being hit by US government price-setting rules as soon as 2028. Shares in Merck, known as MSD outside North America, are down 35 per cent over the past year, giving it a market value of $203bn as of market close on Tuesday.

    Merck’s cancer treatment Keytruda is the world’s top-selling drug with nearly $30bn a year in revenue © David Crosling/EPA-EFE

    As part of the deal, Merck would pay $107 per American depository share for Verona, a 23 per cent premium to the biotech’s closing price on Tuesday, according to three people familiar with the matter. The takeover values the respiratory disease-focused biotech at about $10bn.

    The talks between the companies were at an advanced stage and a deal could be announced as soon as Wednesday, provided there are no last-minute hitches, the people added. Merck declined to comment, while Verona did not immediately respond to a request for comment.

    Verona’s Ohtuvayre, which launched in the US last year after being approved by the Food and Drug Administration for the treatment of COPD in adult patients last year, has got off to a winning start, with 25,000 prescriptions filled by the end of the first quarter, exceeding analysts’ expectations.

    Merck’s acquisition would fast track the international launch of the drug in countries outside the US, the people added. It comes as Merck gears up for a blitz of product launches, with plans to roll out more medicines over the next five years than it has ever done in that timeframe in its history.

    Ohtuvayre was the first completely new inhaled medicine approved as a maintenance treatment for the 8.6mn US patients with COPD, a leading cause of death that destroys lung tissue and function, in the past two decades. Unlike existing COPD drugs, it is not a steroid-based treatment and instead works by inhibiting two different enzymes, working to open up the airways and reduce inflammation.

    Verona, a London-headquartered biotech founded in 2005, has also studied the same treatment in patients with a host of other lung conditions, including bronchiectasis, asthma and cystic fibrosis, as well as in combination with another COPD drug, potentially widening the reach of the drug in the years to come.

    Merck CEO Robert Davis
    Rob Davis became chief executive of Merck in 2021 © Leah Millis/Reuters

    The acquisition of Verona would give Merck, best known as a cancer drugmaker, a stronger foothold in respiratory medicine after the US approval of Winrevair last year, a treatment for a potentially fatal disease affecting the lungs and heart, which it acquired in its $11.5bn buyout of Acceleron Pharma in 2021.

    Since Merck’s chief executive Rob Davis arrived in April 2021, Merck has ranked as one of the most active pharmaceutical groups for acquisitions and licensing deals, as measured by number of deals done and dollars spent. But in recent months investors have clamoured for more deals to offset the looming sales decline from Keytruda’s patent cliff.

    Meanwhile, the life sciences sector has been destabilised this year by the possibility of drug pricing reforms under President Donald Trump’s administration, the threat of tariffs and changes to regulatory and public health agencies under the leadership of top US health official Robert F Kennedy Jr, a known vaccine sceptic.

    Merck’s problems have been compounded by a sales slowdown in China for its top-selling human papillomavirus vaccine Gardasil. Trump’s tariff policy prompted Merck in May to cut its 2025 sales outlook.

    Davis has previously said he is hunting for deals of $1bn-$15bn in value, or even higher if the right target emerges. Earlier this year, Merck struck an up to $2.2bn licensing deal with China-based Jiangsu Hengrui Pharmaceuticals for the global rights to its heart disease drug.

    Continue Reading

  • Morning Bid: Trump tariff volleys met with caution, not chaos – Reuters

    1. Morning Bid: Trump tariff volleys met with caution, not chaos  Reuters
    2. Asia-Pacific markets trade mixed as investors assess Trump’s steep tariffs  CNBC
    3. Stocks drop after Trump announces tariffs on countries including Japan and South Korea  CNN
    4. Markets News, July 8, 2025: S&P 500, Dow Close Slightly Lower as Trade Uncertainty Persists After Trump Extends Deadline on Tariffs  Investopedia
    5. Another tariff delay – Market wrap for the North American session – July 8  marketpulse.com

    Continue Reading

  • The looming ‘patent cliff’ facing Big Pharma – Financial Times

    The looming ‘patent cliff’ facing Big Pharma – Financial Times

    1. The looming ‘patent cliff’ facing Big Pharma  Financial Times
    2. Big Pharma prepare for next patent cliff as blockbuster drugs revenue losses loom: GlobalData  Express Pharma
    3. Pharma industry needs to pivot beyond generics | Policy Circle  policycircle.org
    4. Indian pharma eyes US gains as $63.7 bn patent cliff nears: Analysts  Business Standard

    Continue Reading

  • Real-world Data Shows Teclistamab Can Benefit Many Multiple Myeloma Patients Who Would Have Been Ineligible for Pivotal Trial | News Releases

    Retrospective study revealed efficacy of the bispecific T-cell engager in patients with high-risk, heavily pretreated multiple myeloma, including after prior BCMA therapy 

    PHILADELPHIA – Teclistamab-cqyv (Tecvayli) led to clinically meaningful responses in patients with heavily pretreated multiple myeloma who would have been ineligible for the MajesTEC-1 trial, and identified a novel factor independently associated with outcomes, according to a study published in Blood Cancer Discovery, a journal of the American Association for Cancer Research (AACR).

    Teclistamab-cqyv is a T-cell-engaging bispecific antibody that targets multiple myeloma cells via the B-cell maturation antigen (BCMA) receptor. It received accelerated approval in 2022 for patients treated with four or more lines of prior therapy based on results from the phase I/II MajesTEC-1 clinical trial. However, the potential benefits of the bispecific immunotherapy in populations not represented in the trial, or in the presence of risk factors associated with poorer outcomes, remains an important focus of ongoing clinical investigation.

    “Teclistamab is an important treatment option for patients with relapsed/refractory multiple myeloma but there is still a lot to learn about how to modify risk factors and optimize the use of teclistamab in clinical practice,” said Beatrice M. Razzo, MD, an assistant professor at Thomas Jefferson University, former hematology-oncology fellow at the University of Pennsylvania, and the lead author of the real-world study involving patients treated in a consortium of 15 U.S. academic medical centers.

    In the largest study of its kind to date, Razzo and her team retrospectively analyzed data from 509 multiple myeloma patients, half of whom had received at least six prior treatments. Eighty-nine percent (453) of these patients would have been ineligible for MajesTEC-1, with the most common reasons being prior treatment with another BCMA-targeting therapy (236 patients), cytopenias (189 patients), and an ECOG performance status of two or higher (117 patients). Overall, patients in this study represented a higher-risk population, with more frail individuals and a greater prevalence of multidrug refractory disease and cytogenetic abnormalities, according to Razzo.

    The bispecific antibody reduced disease burden by at least half in 53% (270) of the 506 evaluable patients, with 45% (228) having at least 90% reduction in disease burden (so-called “very good partial response” in the official response criteria). At a median potential follow-up of 10.1 months, half of patients remained free of progression for at least 5.8 months and an estimated 61% were alive at one year. Even with the high prevalence of patients with high-risk features, there appeared to be no increase in adverse event frequency compared to their prevalence in MajesTEC-1 and other real-world analyses of the bispecific antibody’s use.

    Notably, the 56 patients who would have been eligible for MajesTEC-1 had similar overall response rates compared with the registration trial population, 61% and 63%, respectively.

    With regard to MajesTEC-1-ineligible patients, the bispecific antibody also benefited many patients previously treated with BCMA-targeting CAR T cells or the antibody-drug conjugate belantamab mafodotin (Blenrep). Forty percent exhibited “very good partial responses,” including 43% of the 58 patients whose disease had been previously treated with the antibody-drug conjugate and 38% of the 104 patients whose disease had previously been treated with CAR T cells.

    Further analyses revealed that patients who underwent prior BCMA-targeting therapy within nine months of starting teclistamab-cqyv exhibited lower rates of “very good partial responses” and shorter periods of progression-free survival. However, this therapeutic resistance occurred more often in the group recently treated with CAR T cells than in those recently treated with belantamab mafodotin, who responded at a rate comparable to BCMA therapy-naïve patients.

    “These findings in patients with prior BCMA CAR T cell exposure suggest that increased spacing may allow for the recovery of T-cell fitness or the reemergence of BCMA-expressing subclones. Alternatively, a longer interval may simply reflect less aggressive disease biology,” explained Razzo.

    Extensive pretreatment bone marrow infiltration by myeloma cells (60% fraction or higher) or indirect markers of high disease burden such as anemia, thrombocytopenia, or low absolute lymphocyte count were also significantly associated with lower rates of “very good partial responses” and shorter periods of progression-free survival. The study also found that elevated baseline ferritin was associated with inferior outcomes independently of disease burden.

    “Nevertheless, teclistamab-cqyv remains an important treatment option for patients with late-line, relapsed or refractory multiple myeloma, and should be considered even in those with prior BCMA exposure or markers of high disease burden and inflammation.” said Razzo.

    “Our results highlight the complex interplay between real-time clinical parameters and baseline disease features in influencing patient outcomes and suggest that the former may be a more reliable indicator of disease biology than the latter in these patients, but there is still a lot to learn,” she added.

    To that end, Razzo and her colleagues are focused on their ongoing phase II trial investigating limited-duration drug dosing in patients with advanced multiple myeloma.

    Limitations of the study include the nonstandardized nature of the real-world data as well as the lack of a centralized independent review or adjudication process for response and toxicity assessments. Information regarding the dose intensity of teclistamab-cqyv given to patients was also not available for analysis.

    The study was supported by a  National Cancer Institute training grant. Razzo has received advisory board honoraria from Johnson & Johnson.

    Download a photo of Razzo

    Continue Reading

  • Saudi Riyal further strengths against Pak rupee– 9 July 2025

    Saudi Riyal further strengths against Pak rupee– 9 July 2025

    KARACHI – The buying rate of Saudi Riyal (SAR) registered another increase of five paisa against Pakistani rupee in open market on Wednesday as 1 SAR stood at Rs75.82.

    The selling rate of Saudi Riyal also moved up accordingly and hovered at Rs76.19.

    The Saudi riyal to Pakistani rupee exchange rate holds major significance for Pakistan due to remittances from overseas workers in Saudi Arabia.

    A stronger riyal increases the value of remittances, supporting Pakistan’s economy, boosting foreign reserves, and helping stabilize the national currency against inflationary pressures.

    1,000 Saudi Riyal in Pak Rupee

    As the SAR buying rate stood at Rs75.82, an individual can exchange 1,000 Saudi Riyals for Rs75,820 in open market.

    Currency exchange is vital for global trade, travel, and investment. It enables countries to buy and sell goods and services internationally by converting one currency into another. Exchange rates influence inflation, interest rates, and economic stability. For developing countries, like Pakistan, currency exchange impacts import costs, remittances, and foreign debt payments.

    Meanwhile, the workers’ remittances from overseas to Pakistan recorded a significant growth of 28.8 percent during eleven months of fiscal year 2024-25, reached nearly $35 billion. During the period from July 2024 to May 2025, monthly inflows in May increased to $ 3.69 billion.

    “Cumulatively, with an inflow of US$ 34.9 billion, workers’ remittances increased by 28.8 percent during Jul-May FY25 compared to US$ 27.1 billion received during Jul-May FY24,” the State Bank of Pakistan reported on Wednesday.

    Pakistanis living in Saudi Arabia topped the chart as they sent $913.3 million in wake of remittances in May 2025 followed by $754.2 million from the UAE.

    Continue Reading

  • The Real AI Race | Foreign Affairs

    The Real AI Race | Foreign Affairs

    Discussions in Washington about artificial intelligence increasingly turn to how the United States can win the AI race with China. One of President Donald Trump’s first acts upon returning to office was to sign an executive order declaring the need to “sustain and enhance America’s global AI dominance.” At the Paris AI Action Summit in February, Vice President JD Vance emphasized the administration’s commitment to ensuring that “American AI technology continues to be the gold standard worldwide.” And in May, White House AI and Crypto Czar David Sacks cited the need “to win the AI race” to justify exporting advanced AI chips to the United Arab Emirates and Saudi Arabia.

    Given the prospect that AI could transform the power and prosperity of nations in the decades to come, it is better to win the race than lose it. But determining who is ahead depends on what it means to win. A common definition is being the first to cross the threshold of artificial general intelligence, which in basic terms is an AI model that is as smart or smarter than the top human experts across a wide range of cognitive tasks. AGI could unlock extraordinary breakthroughs in science, technology, and economic productivity—and the first country to develop it could reap disproportionate benefits.

    But the race to AGI is not the only critical race in the AI contest. Militaries and intelligence agencies must harness AI’s transformative potential and mitigate its disruptive effects. Similarly, countries stand to gain a competitive edge if they can adopt AI at scale across the economy and society. Governments are also battling to create and own the standards, supply chains, and infrastructure that will undergird the global technological ecosystem. And all must avoid a race to the bottom in AI safety by working—sometimes together—to manage security risks from misused or rogue AI.

    Taking these additional AI races into account makes the United States’ position look precarious. Although U.S. companies maintain a meaningful—if narrowing—lead at the frontier of AI research and development, Washington could lose other AI races. China has considerable advantages, and neither superpower seems eager to cooperate to avoid catastrophe. And given AI’s world-changing potential, the stakes are profound: losing risks relegating the United States to economic dependency, military vulnerability, and diminished global leadership. That bleak future can still be avoided. But the United States will need to muster a coherent AI strategy, one that balances innovation, integration, and risk mitigation to translate the country’s immense technological dynamism into enduring strategic advantage.

    THE RACE TO INNOVATE

    The race to AGI is the most visible and immediate of the AI contests. Private companies such as OpenAI, Anthropic, and Google DeepMind in the United States and DeepSeek in China are rushing to innovate, supported by their respective governments. No one knows exactly how the technology will evolve. Large language models could be the first signs of emerging AGI, or true AGI could manifest suddenly when AI models pass a certain threshold. Either way, AGI has enough potential to transform the sources of national power and competitiveness that the world’s two AI leaders have a substantial interest in securing a first-mover advantage.

    U.S. AI labs currently have a discernible edge, helped along by semiconductor export controls designed to maintain the United States’ computational advantage over China. But this lead is fragile. China’s indigenous innovation, circumvention of export controls, and intellectual property theft have kept the country in a close second place. Its leading AI companies, such as DeepSeek, are developing technologies that trail their U.S. counterparts by mere months. And Beijing’s centralized approach might help it nurture, consolidate, and harness private-sector innovations more quickly than Washington can.

    The race to artificial general intelligence is not the only race in the AI contest.

    The United States’ open system, meanwhile, fosters innovation but is inherently vulnerable to espionage and the rapid diffusion of algorithmic advances. Breakthroughs in algorithmic design or alternative paradigms for AI development could diminish the importance of U.S. semiconductor dominance, and their spread could enable China’s AI labs to leapfrog American competitors. The Trump administration, driven by other political priorities, is also pulling back investment in basic AI research and development and discouraging talented foreign nationals from working in the United States, potentially setting back U.S. AI efforts over the next several years.

    The U.S. private sector, moreover, responds to commercial imperatives that are not always consistent with national priorities. AI firms, for example, will be tempted to build AI computing power wherever there is available energy infrastructure—whether or not it is based in the United States. Favorable regulatory environments and abundant resources in the Middle East are already proving attractive. The world’s first five-gigawatt AI data center cluster will be built in the UAE, not the United States—a development enabled by the Trump administration’s recent decision to export hundreds of thousands of leading-edge AI chips to Abu Dhabi. Washington does benefit from this arrangement, and U.S. firms including OpenAI and Microsoft are slated to operate most of the data centers’ capacity. But moving crucial infrastructure offshore, where security may be lax, could also provide a backdoor for China and other competitors to acquire advanced computing resources and AI models.

    Even if the United States can hold on to its lead in the innovation race, that may not be enough. Current market trends suggest that frontier AI models are becoming so widely accessible and undifferentiated that they give no one a clear technological edge. If that trend holds when AGI emerges, victory will depend on effective AI adoption—and there is no guarantee the United States will come out on top.

    SECURING THE EDGE

    In the realm of national security, effective AI adoption requires both understanding the capabilities enabled (and threats posed) by frontier AI and integrating AI into existing structures in ways that secure a decisive military edge. Integration of AI promises to enhance intelligence processing, accelerate data-driven decision-making, optimize logistics and resource allocation, enable sophisticated autonomous systems, and possibly even lead to the development of a “wonder weapon”—such as a cyberweapon that could cripple an adversary’s critical infrastructure and command and control or, used defensively, make a country invulnerable to cyberattacks.

    The U.S. government and private industry need to work together to achieve AI integration, but their current cooperation remains troublingly limited. National security agencies lack early access to the latest AI models, which would speed up the process of incorporating the latest technologies into their workflows. Partnerships between leading AI labs and the Pentagon and other national security agencies are only in nascent stages. And lengthy procurement cycles, operational cultures that are resistant to change, a lack of infrastructure and data, and misunderstandings about what AI can achieve—both underestimating and overestimating its abilities—hamper the government’s ability to take full advantage of innovations coming out of Silicon Valley. Although these problems are widely acknowledged, fixing them has proven difficult.

    China’s authoritarian system, meanwhile, eases civil-military integration, providing it with a structural edge in AI adoption. State mandates ensure that technological advances are rapidly translated into military and intelligence capabilities. The People’s Liberation Army has embraced AI and is actively seeking contributions from the commercial and academic sectors. Making use of AI competitions and public purchasing platforms designed to translate civilian AI research to military applications, it plans to field “algorithmic warfare” and “network-centric warfare” capabilities by 2030. More than merely using algorithms in weapons systems, this entails a transition to a new type of warfare in which military superiority depends on the speed, sophistication, and reliability of those algorithms.

    Remaining on the cutting edge of innovation is necessary but not sufficient to win the race in the national security space. The United States could produce scientific and technological breakthrough after breakthrough but still fail to recognize the point at which AI opens a new technological pathway to a revolutionary military or intelligence capability. Washington’s bureaucratic structures, designed for incremental improvements to existing systems, often make it difficult to imagine left-field possibilities for emerging technologies. Beijing’s centralized decision-making system, in comparison, could identify and exploit a disruptive pathway much faster, potentially leaving the United States technologically superior but strategically outmaneuvered.

    THE INTEGRATION IMPERATIVE

    The winner of the AI race will also need to integrate AI into the national economy—to ensure that AI is widely accessible and is diffused across the education, energy, finance, health, logistics, and manufacturing sectors. The U.S. technology companies that drive consumer and business AI applications, a vibrant venture capital ecosystem that funds innovation, relatively high digital literacy, and extensive digital infrastructure all provide the United States notable advantages. Yet success is not guaranteed. If corporate and governmental actors at all levels fail to create the right incentives for integration and build sufficient public trust in AI, the private sector could struggle to adopt AI quickly enough to capitalize on the benefits of enhanced productivity and new value creation. There is also a danger that AI will not simply augment human labor but replace it. Anthropic CEO Dario Amodei has recently warned that AI could lead to as much as 20 percent unemployment in the United States within five years—an outcome that could deeply destabilize both the economy and American society.

    Meanwhile, China may be poised to perform surprisingly well in the race for economic adoption. Chinese business leaders are already more focused on AI applications than on developing AI models. DeepSeek’s open-source models, for example, are driving down costs for all Chinese AI models, which enables more businesses to experiment with the technology. This could give China an edge in creating game-changing products. The Chinese government is also less exposed to the political consequences of AI replacing labor. Whereas automating jobs raises alarm in Washington, Beijing could even welcome AI adoption as a solution to China’s labor shortages brought by a rapidly aging and shrinking population.

    Even if the United States can keep its lead in innovation, that may not be enough.

    Even if the United States adopts AI across its economy as aggressively as China does, it may lose the overall race if China is better positioned to capitalize on the manufacturing advances enabled by AI, particularly in the realm of robotics. China leads the world in industrial robot installations: Chinese manufacturers purchased half of the global market share in 2024, and the country’s robots per employee significantly exceeded the global average. Extreme automation is becoming more common in the manufacturing sector with the proliferation of “dark factories,” such as the electronics company Xiaomi’s smartphone facility that operates 24/7 without human workers. As AI makes strides in spatial reasoning and embodied intelligence—AI that enables robots to interact with and learn from their physical environment—factory robots may become able to perform a much wider array of complex physical tasks.

    Although U.S. firms excel in software and services—areas that are also expected to make significant productivity gains as a result of AI adoption—the United States has ceded ground to China in recent decades in physical industries, including manufacturing, logistics, energy, and infrastructure. With its state-driven industrial policy and massive manufacturing base, China can deploy AI at scale within these sectors and might unleash dramatic productivity gains that lead it to finally surpass the U.S. economy.

    STACKING THE DECK

    The world’s tech powers are also racing to provide the digital infrastructure that will undergird the global development, deployment, and use of AI. Although this is primarily a competition between the United States and China, other established tech powers (such as France, Japan, the Netherlands, South Korea, Taiwan, and the United Kingdom) and ambitious emerging players (such as Brazil, India, Saudi Arabia, and the UAE) are joining the contest, too. Each participant aims to control the data, the chips and data centers, and the foundational models required for AI use, as well as exert influence over global AI norms and standards. As Sacks, the White House czar, recently put it, “If 80 percent of the world uses the American tech stack, that’s winning. If 80 percent uses Chinese tech, that’s losing.”

    Export controls on semiconductor chips have given the United States a meaningful edge. U.S. companies have access to the chips they need for computational power, and much of the world wants U.S. chips because they are the best on offer. The Trump administration is seeking to capitalize on this advantage by “flooding the zone” with U.S. chips and data centers, starting in partner countries such as Saudia Arabia and the UAE. The idea is to lock in the use of U.S. technology in places where market forces encourage massive investments in digital infrastructure.

    But in countries with lower incomes, fewer customers, and less basic infrastructure such as broadband connectivity and electricity, Washington’s strategy of following market forces will lead to underinvestment. This is the dynamic across a broad group of countries in Africa, Latin America, the Middle East, and South and Southeast Asia that are turning to AI to boost their economic growth. China is positioned to outcompete the United States in these places by providing less advanced and significantly cheaper AI models—as well as subsidizing the physical and digital infrastructure needed to run them. It may not currently be able to export any top-of-the-line chips, but for many developing countries where cost and accessibility are more important than cutting-edge performance, China’s “good enough” offerings could prove highly attractive.

    An AI chip on display in San Jose, California, June 2025 Max A. Cherney / Reuters

    Ceding these emerging markets risks a future in which the United States wins the technological race at the frontier but surrenders leadership of the global AI ecosystem to China. The consequences for Washington extend beyond lost geopolitical influence and commercial opportunities. Chinese AI models and infrastructure frequently embody digital authoritarian values, enabling Beijing to export mechanisms of state control and shape historical and political narratives beyond its borders. They facilitate surveillance by powering facial and voice recognition systems and analyzing vast amounts of data to monitor individuals and flag “suspicious” behavior. They automatically censor content critical of the Chinese Communist Party or related to sensitive topics such as Tiananmen Square, Taiwan, Hong Kong, the Uyghurs, or Chinese leader Xi Jinping. Their algorithms also curate and disseminate pro-Chinese propaganda. In contrast, U.S. AI models generally reflect stronger commitments to democratic norms, transparency, privacy safeguards, user choice, and data protection frameworks, helping reduce opportunities for government abuse. A critical step toward ensuring the technologies shaping modern life across the world align with democratic values is for Washington to proactively incentivize U.S. AI firms to invest and build infrastructure in developing countries.

    Poor policy choices could set the United States back in the race to build and manage the world’s AI infrastructure. Overly restrictive export controls could alienate allies or drive countries currently on the fence toward Chinese products. Conversely, applying too little control over advanced AI chips could inadvertently create opportunities for Chinese companies to acquire or remotely access them, potentially accelerating China’s technological innovation. And if Washington cannot articulate a compelling vision for technological governance—one that carefully balances national security with economic openness and democratic values—potential international partners may turn elsewhere. China is not just selling AI; it offers a comprehensive toolkit for rapid modernization on financially and politically appealing terms to a substantial portion of the world. For a developing country eager to harness AI for economic gains and improved governance, the Chinese offer is often the most practical and readily available path forward.

    A RACE TO THE BOTTOM?

    Even as the United States and China compete in the AI race, they cannot forget that AGI and other highly capable AI models create potential threats. It is imperative that neither competitor allows its rapid development and deployment of AI to make a disaster more likely. A nonstate actor or rogue state weaponizing AI models, unintentional military escalation caused by AI, or a loss of control of superintelligent systems could prove catastrophic. Preventing such outcomes requires that AI powers avoid cutting corners on safety in their haste to compete.

    The most pressing near-term catastrophic risks are that nonstate actors with access to advanced AI systems could launch large-scale cyberattacks that devastate financial systems or design and release highly lethal and transmissible pathogens. These hazards are no longer confined to the realm of science fiction. Companies at the forefront of AI development predict that their internally defined thresholds for dangerous capabilities—measured as “uplift,” or the degree to which an AI model significantly enhances a malicious actor’s abilities—are likely to be crossed this year. Another rapidly approaching threat is the potential emergence of a superintelligence misaligned with human values or intentions, pursuing actions that endanger human well-being because of flawed design, ambiguous instructions, or unforeseen consequences. Growing evidence of frontier AI models exhibiting deceptive or scheming behaviors makes this risk increasingly credible.

    Both Washington and Beijing have an interest in preventing the proliferation of dangerous AI capabilities and the emergence of rogue AGI. This common ground creates an opportunity for cooperation between the two AI superpowers—even amid their intense technological competition—to better understand risks of misuse and misalignment and to identify and develop effective mitigation measures.

    For Washington, seeking ways to mitigate threats from AI—an imperative the Trump administration has recognized—is sound policy regardless of what other AI powers do. Even if rogue AI does not lead to global calamity, a major AI-related incident originating from the United States, whether accidental or through negligence, would undermine confidence in American technology. And if the United States is seen as unable to manage the immense power of AI, its global leadership and moral authority would be called into question, and China could exploit the resulting power vacuum by promising stability and control.

    RECIPE FOR SUCCESS

    The trajectories of the various AI races between China and the United States are tightly intertwined. Winning the race to AGI development, for example, will boost the leading country’s national security, economic vitality, and global technological influence. And the competitive pressures unleashed by the races to develop and adopt AI exacerbate the risk of a catastrophic outcome as haste and rivalry undercut safety—a danger no country can outrun. Success in the AI race therefore requires a strategy that advances progress across several fronts simultaneously while managing the security risks of unchecked AI.

    As part of a holistic strategy, Washington must make every effort to avoid being caught off guard by AI advances in Silicon Valley, China, and emerging AI hubs around the world. Being surprised could mean failing to recognize the emergence of new threats or missing opportunities to capitalize on AI progress ahead of China. To prevent this, the U.S. government must maintain close communication with domestic industry leaders and closely monitor imminent technological breakthroughs abroad. The Commerce Department’s repurposing of its AI Safety Institute, now called the U.S. Center for AI Standards and Innovation, to focus on working with industry to research and test frontier AI is a step in the right direction. National security departments and agencies, too, should remain apprised of the latest frontier AI developments and explore potential use cases. Likewise, the intelligence community must expand its monitoring of foreign AI efforts, particularly focusing on China’s advancements and objectives, as well as those of emerging AI powers in the Middle East.

    The Trump administration should also identify ways to facilitate frontier AI development. It must ensure that AI companies have access to the resources they need for AI model development and deployment, including vast computational power (in the form of semiconductors), high-quality data, world-class talent, and sufficient energy supplies. It will be important not to create new problems in the process; to meet AI’s growing energy demands without exacerbating climate change, for example, Washington should invest in cleaner energy sources such as nuclear power.

    The private sector could struggle to adopt AI quickly enough to capitalize on its benefits.

    Washington must defend U.S. technological superiority, too. To ensure that AI advancements are not rapidly replicated by competitors, the U.S. government will need to enforce stringent controls over technologies such as advanced semiconductors and manufacturing equipment, strengthen security measures at research labs and data centers to prevent espionage and intellectual property theft, and require rigorous user verification on cloud computing platforms so that they do not become unwitting tools for an adversary’s technological advancement.

    To keep the United States at the forefront of innovation while safeguarding national interests, the U.S. government must develop a scalable and adaptive public-private partnership model to cooperate with companies working on frontier AI. These initiatives should help the government ramp up its adoption of advanced AI and promote prudent security practices. U.S. AI companies can benefit from access to sensitive government intelligence about adversaries attempting to target them, and both the public and private sectors can benefit from co-developing AI applications that can enhance national security, such as advanced cybersecurity and biodefense tools.

    As China expands its industrial capacity using AI and robotics, policymakers in Washington must also broaden AI adoption beyond the technology sector. The Trump administration should work with Congress to launch a dedicated “industrial AI” initiative to accelerate research, development, and investment in robotics and AI deployment across the manufacturing, logistics, energy, and infrastructure sectors. With tax credits, innovation grants, and public-private pilot projects, the government can incentivize factories, warehouses, and transportation hubs to integrate AI-driven systems, bridging the gap between the United States’ cutting-edge software capabilities and its lagging factory floors.

    Policymakers must also act now to help the workers who will lose their jobs to AI in these industrial sectors. This means significantly increasing investments in STEM education, vocational training, and retraining and upskilling programs—services that would enable workers displaced by automation to swiftly transition into new roles, such as robot maintenance or AI system supervision. To provide clarity for businesses and protections for workers in an AI-centric economy, labor laws and regulations also require updates. As companies increasingly use algorithms to schedule work shifts and more employees work on short-term contracts, wage-and-hour laws should be modernized to ensure transparent, fair compensation and clearly defined working hours. Workplace safety guidelines will need to be revised to incorporate standards for safe human-robot interaction on factory floors. Strengthening unemployment benefits and other forms of direct income support for people disproportionally affected by automation will also be crucial to mitigating the potentially destabilizing consequences of significant labor displacement.

    AI powers must avoid cutting corners on safety in their haste to compete.

    If the United States is to lead the global AI technology ecosystem, it will also need to provide advanced AI and data centers to more than just wealthy countries. To compete with China’s “good enough” AI systems across the developing world, the Trump administration should explore public-private partnerships to offer generous access to U.S. cloud computing systems to researchers and entrepreneurs in these countries. It should also scale up government-backed financial tools—such as low-interest loans, loan guarantees, equity investments, political risk insurance, and tax incentives—through agencies such as the International Development Finance Corporation. These incentives should be geared toward building digital infrastructure in important emerging markets, such as in Brazil, Ghana, India, Indonesia, Kenya, Mexico, Nigeria, the Philippines, and Vietnam.

    Finally, the Trump administration must take steps to reduce the risk of worst-case scenarios—and prepare for those contingencies should they arise. It should run tabletop exercises and crisis simulations of cases involving catastrophic misuse of AI or rogue superintelligence. Doing so would give senior leaders opportunities to rehearse crisis responses, identify gaps in readiness, and improve their decision-making under pressure.

    The United States and China, moreover, have a profound obligation to themselves and the world to collaborate to reduce AI risks. Following the 1962 Cuban missile crisis, the United States and the Soviet Union built guardrails around their nuclear competition. They cooperated on negotiations for the 1970 Nuclear Non-Proliferation Treaty, recognizing that an uncontrolled race to the nuclear frontier could send humanity hurtling off a cliff. Washington and Beijing today need to chart a similarly narrow path between AI competition and collaboration. They could start with a bilateral agreement to share AI incident information and exchange best practices on AI safety, control, and alignment with human values. Further talks should focus on how to handle scenarios of misused or uncontrolled AGI.

    The notion of a singular AI race between the United States and China fails to capture the true complexity of the rivalry unfolding today. The challenge is to win not one definitive contest but a multifront competition whose outcome will shape the international balance of power. Navigating these deeply intertwined domains of technological and strategic AI competition demands that Washington adopt a holistic strategy. Without it, success in one race could create vulnerabilities in another—and neglecting any of them risks irreparably weakening the United States’ global position.

    Loading…

    Continue Reading

  • A new twist on an old bet with Buffett

    A new twist on an old bet with Buffett

    Ted Seides is the founder of Capital Allocators and former president of Protégé Partners.

    On a slow summer day 18 years ago, I began communicating with Warren Buffett about a bet that pitted the performance of hedge funds against the S&P 500.

    The suggestion turned into a charitable 10-year wager from January 1, 2008 to December 31, 2017. Carol Loomis announced it in Fortune as “Buffett’s Big Bet”. It looked good for the hedge funds in the early years around the global financial crisis, but the market rallied strongly thereafter. By the time of Berkshire Hathaway’s 2016 annual report, Buffett was able to take a victory lap.

    Lots of virtual ink has been spilled about what the bet meant — some of it on pink pixels. Warren initially assessed his odds of winning at 60 per cent (but wrote in his 2016 annual letter as if victory was preordained). I initially called it at 85 per cent in our favour. Lots of outcomes could have happened, but only one did. In retrospect, I was overconfident, but I caution those who read too much into the results.

    Annie Duke calls this “resulting, a behavioural bias where people judge the quality of a decision based on the outcome rather than on the decision process itself. I still believe the odds were heavily in favour of hedge funds at the time, and an unprecedented act by the Fed bailed out the market from what could have been a lost decade.

    Regardless of cause and effect, the bet led to unanticipated connections, relationships, and experiences. Warren and I met for dinner nearly every year, typically accompanied by a guest or two. Those guests included Todd Combs; Ted Weschler; my partner at the time and now Treasury secretary, Scott Bessent; hedge fund founder Bobby Jain; podcast star Patrick O’Shaughnessy; Permanent Equity founder Brent Beshore, and investor Steve Galbraith — which led directly to Warren honouring Steve’s close friend Jack Bogle at Berkshire’s annual meeting in 2017. I had a chance to meet Charlie Munger, who stereotypically said my bet was “stupid”.

    Most importantly, with Warren’s win, Girls Inc of Omaha received over $2mn and purchased the Protégé House to provide residential support and guidance to Girls Inc. alumni. The growth of the $1mn bet into $2mn in proceeds is a story unto itself. We initially split the purchase of a zero-coupon bond that would mature in 10 years at $1mn. After the Fed dropped rates to zero, the $640,000 outlay had grown around 50 per cent. We decided to sell the bonds and buy Berkshire Hathaway stock, coincidentally shortly before Warren repurchased shares for the first time. The performance of the collateral for the bet far surpassed both the S&P 500 and the hedge funds.

    Since then, many others have naturally reached out to me and proposed many different wagers.

    Each came with conviction — Bitcoin HODLers, China bulls, emerging market mean-reverters, and Japan governance reformers. I don’t know if any communicated with Warren, but I didn’t see a relevant comparison in any of them.

    A few weeks ago though, I thought of another bet that has equal — or greater — importance than the first. What’s the bet you ask? Private equity versus the S&P 500.

    Comparing a portfolio of North American buyouts to the S&P 500 has important consequences, as private equity enters wealth management and seeks to access pension plans. In fact, I’d argue that this match-up could help shed light on one of the thorniest, most contentious debates in finance today.

    I imagine we know what Warren thinks — high fees and extra expenses will doom private equity investors. A lot of outside factors could have impacted the result of our first bet (I wrote about it here), but that’s unlikely to happen with this comparison. This bet is much closer to faithfully representing Warren’s initial premise: that intelligent professionals with strong economic incentives to perform still cannot overcome the high fees they charge.

    Both the S&P 500 and North American buyouts offer diversified exposure to the US economy. Businesses in public and private markets are similarly impacted by macroeconomic variables and have common geographic and sector exposure. (While the Mag 7 dominates the S&P 500, software and technology are the most represented sectors in buyouts.) Their pricing (P/E of stock and EV/EBITDA of buyouts) is correlated, in part because transactions between the two markets can arbitrage large pricing discrepancies.

    The question, then, is whether their differences are enough for private equity to make up for the costs of doing business. Leverage, size, dispersion, illiquidity, and control each — in theory — positively impact private equity returns relative to the S&P 500.

    — Leverage: The S&P 500 is approximately 0.6x debt-to-equity. Private equity is 1.5x. Assuming positive returns over a decade and a ROA above the cost of capital, leverage would boost private equity returns relative to the market.

    — Size: Private equity-owned businesses are smaller than those in the S&P 500. Historically, small-cap companies outperformed large ones, although that hasn’t been true for a while.

    — Dispersion: The dispersion of returns across private equity managers has been far wider than those in the public equity markets. This creates an opportunity to outperform within the asset class.

    — Illiquidity: By design, private equity is illiquid. While illiquidity may not impact returns directly, it likely helps investors avoid getting in their own way. Dalbar’s quantitative analysis of investor behaviour consistently shows that public market investors earn far lower returns than the investments themselves.

    — Control: Private equity firms are control owners of businesses and compensate management teams aligned with results. Public companies tend to have less engaged shareholders and less executive ownership.

    Putting numbers to these concepts: assuming a 10 per cent return of the S&P 500 over 10 years, private equity would need to deliver approximately a 15 per cent gross return to beat the index. Higher leverage can make up 2-3 percentage points of that gap at current interest rates and spreads. However, the forty-year tailwind of declining interest rates will no longer support private market returns as it did in the past.

    Next, smaller companies can grow faster than larger ones, a factor that could benefit private markets over time. Over the last century, small-cap stocks in the US have outperformed large by approximately 1.5 per cent per year, although that premium has been slightly negative since the GFC.

    Adding up those two effects, private equity’s structural benefits could make up perhaps 80 per cent of the gap. The rest is up to allocators to select top private equity managers, private equity firms to make above-average investments, and management teams to deliver better operating results.

    I described twelve examples of private equity transactions in my book, Private Equity Deals. These managers have many tools at their disposal to create value. When reading their stories, it’s hard to imagine they won’t find a way to deliver.

    But as I learned from betting with Warren, the future is much harder to predict than the past. When you add it up, I’d put the odds of private equity outperforming the S&P 500 net of fees at around 40 per cent, which says next to nothing about what investors will actually experience.

    Over the next few months, I’m going to speak to some podcast guests to see if we can identify an investable option to represent North American buyouts, and someone to take each side of the bet.

    It might be fun to create a shadow wager starting on January 1 and report the results annually for the next 10 years. I’m even more excited to see if any unexpected benefits and connections surface this time around.

    So . . . what do you think?

    Continue Reading